Ripening Approaches for Prompt Induction and Delivery - Sequential Versus Concurrent Dilapan-S and Misoprostol to Achieve Vaginal Delivery (RAPID-DS)
Starting soon · Not applicable
Conditions studied: Nulliparous Women Who Scheduled for Labor Induction, Pregnancy
In brief
The purpose of this study is to compare the effectiveness of sequential versus combined multimodal cervical ripening strategies to achieve vaginal delivery within 24 hours among nulliparous patients with singleton, vertex pregnancies at term undergoing induction of labor.
Key facts
- Study ID
- NCT07717502
- Run by
- Ochsner Health System
- People needed
- 260
- Starts
- 2026-08-01
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-07-21
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Nulliparous patients with singleton pregnancies with vertex lie at term receiving prenatal care that are eligible for outpatient cervical ripening will be eligible
You may not qualify if…
- age less than 18,
- suspected major fetal anomalies (including suspected or proven chromosome anomalies, congenital cardiac disease expected to require neonatal intervention, and multiple anomalies suggestive of a complex syndrome),
- fetal growth restriction
- oligohydramnios
- prior full thickness
- uterine scar
- placenta previa,
- low-lying placenta,
- premature rupture of amniotic membranes,
- cervical dilation > 2 cm
- modified Bishop score > 4
- residence greater than 60 minutes from the hospital
Where it is running
- Ochsner Baptist — New Orleans, Louisiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.